2016
DOI: 10.1016/j.gene.2015.08.067
|View full text |Cite
|
Sign up to set email alerts
|

Targeted therapeutic delivery using engineered exosomes and its applications in cardiovascular diseases

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
96
0

Year Published

2016
2016
2022
2022

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 132 publications
(96 citation statements)
references
References 94 publications
0
96
0
Order By: Relevance
“…Furthermore, since exosomes possess some properties such as biocompatibility, biological barrier permeability, low toxicity and low immunogenicity, which are good for therapeutic delivery [90, 91]. Exogenous miRNAs, siRNAs, and even drugs could be encapsulated into the naïve exosomes or engineered exosomes.…”
Section: Translational Applications Targeting Exosomementioning
confidence: 99%
See 1 more Smart Citation
“…Furthermore, since exosomes possess some properties such as biocompatibility, biological barrier permeability, low toxicity and low immunogenicity, which are good for therapeutic delivery [90, 91]. Exogenous miRNAs, siRNAs, and even drugs could be encapsulated into the naïve exosomes or engineered exosomes.…”
Section: Translational Applications Targeting Exosomementioning
confidence: 99%
“…Exogenous miRNAs, siRNAs, and even drugs could be encapsulated into the naïve exosomes or engineered exosomes. The proven technology that packages the therapeutic miRNAs and siRNAs into engineered exosomes could be achieved by the following means: 1) co-transfection into the donor cells with one plasmid or virus encoding the precursor miRNAs or siRNAs, and the other plasmid encoding fusion targeting cassette, respectively [90]; 2) electroporation of synthetic miRNAs or siRNAs into purified exosomes directly [92, 93]; 3) transient transfection of miRNAs by using commercial available transfection reagents [94]. In addition, permeabilization with soponin, sonication, or extrusion could increase the loading efficiency [95].…”
Section: Translational Applications Targeting Exosomementioning
confidence: 99%
“…They revealed that miRNAs derived from noncancerous cells can be transferred to cancerous cells, then inhibiting tumor cell proliferation [185]. Furthermore, researchers observed no overt side effects on exosome-mediated gene delivery [186, 187]. These studies indicate that miRNAs which specifically target kinds of FOX proteins can be loaded into exosomes and then be transported to cancer cells and therefore may be developed as possible anticancer drugs.…”
Section: The Microrna/fox Signalings In Cancer Treatmentmentioning
confidence: 99%
“…The regulatory machinery of exosomes that is associated with production and cellular uptake remains largely unknown. Nonetheless, the engineering of exosomes for therapeutic control of diseases, including cancer, indicated promising results (11)(12)(13)(14)(15)(16).…”
Section: Introductionmentioning
confidence: 99%